Amneal Pharmaceuticals Inc (FRA:2DT)
€ 7.25 -0.05 (-0.68%) Market Cap: 2.31 Bil Enterprise Value: 4.84 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 66/100

Q1 2024 Amneal Pharmaceuticals Inc Earnings Call Transcript

May 03, 2024 / 12:30PM GMT
Release Date Price: €5.75 (+1.77%)
Operator

Good morning, and welcome to the Amneal Pharmaceuticals First Quarter 2024 Earnings Call. I will now turn the call over to Amneal's Head of Investor Relations, Tony Dimeo.

Tony Dimeo
Amneal Pharmaceuticals Inc - Head of IR

Good morning, and thank you for joining Amneal Pharmaceuticals' First Quarter 2024 earnings call. Today, we issued a press release reporting Q1 results. The earnings press release and presentation are available at annual.com. Certain statements made on this call regarding matters that are not historical facts, including but not limited to, management's outlook or predictions are forward-looking statements that are based solely on information that is now available to us. Please see the section entitled Cautionary statements and forward-looking statements for Factors that may impact future performance. We also discuss non-GAAP measures. Information on use of these measures and reconciliation to GAAP in the earnings release and presentation.

On the call today are Chirag and Chintu Patel, Co-Founders and Co-CEOs; Tasos Konidaris, CFO

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot